UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333,789 | -87.0% | 49,745 | -77.9% | 0.00% | -100.0% |
| Q2 2023 | $2,574,213 | -59.7% | 224,626 | -29.3% | 0.00% | 0.0% |
| Q1 2023 | $6,395,257 | -15.3% | 317,540 | -4.7% | 0.00% | -50.0% |
| Q4 2022 | $7,552,647 | +20.8% | 333,156 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $6,254,000 | +20.3% | 333,334 | +19.5% | 0.00% | +100.0% |
| Q2 2022 | $5,200,000 | -57.3% | 278,958 | -58.6% | 0.00% | -50.0% |
| Q1 2022 | $12,190,000 | -17.1% | 674,565 | -4.9% | 0.00% | -33.3% |
| Q4 2021 | $14,706,000 | -45.2% | 709,041 | -15.4% | 0.00% | -40.0% |
| Q3 2021 | $26,814,000 | +29.9% | 837,659 | +25.0% | 0.01% | +25.0% |
| Q2 2021 | $20,642,000 | -12.2% | 670,165 | -3.9% | 0.00% | -20.0% |
| Q1 2021 | $23,499,000 | -0.3% | 697,514 | +6.9% | 0.01% | 0.0% |
| Q4 2020 | $23,565,000 | +5.0% | 652,249 | +7.1% | 0.01% | -16.7% |
| Q3 2020 | $22,438,000 | -7.8% | 609,237 | +12.8% | 0.01% | 0.0% |
| Q2 2020 | $24,328,000 | +5.3% | 539,914 | +10.9% | 0.01% | -25.0% |
| Q1 2020 | $23,098,000 | -37.7% | 486,801 | -5.9% | 0.01% | -20.0% |
| Q4 2019 | $37,068,000 | +123.4% | 517,275 | +22.7% | 0.01% | +100.0% |
| Q3 2019 | $16,596,000 | +206.7% | 421,659 | +508.9% | 0.01% | +400.0% |
| Q2 2019 | $5,411,000 | +147.0% | 69,246 | +88.5% | 0.00% | 0.0% |
| Q1 2019 | $2,191,000 | +305.7% | 36,741 | +96.0% | 0.00% | – |
| Q4 2018 | $540,000 | -20.8% | 18,747 | 0.0% | 0.00% | – |
| Q3 2018 | $682,000 | +8.6% | 18,747 | +12.8% | 0.00% | – |
| Q2 2018 | $628,000 | +121.9% | 16,618 | -2.9% | 0.00% | – |
| Q4 2015 | $283,000 | -53.4% | 17,111 | -42.3% | 0.00% | – |
| Q3 2015 | $607,000 | -24.2% | 29,661 | 0.0% | 0.00% | – |
| Q2 2015 | $801,000 | +11.1% | 29,661 | 0.0% | 0.00% | – |
| Q1 2015 | $721,000 | – | 29,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |